Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-15-0583
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology
AllergyImmunology
2018English

Targeting Mesothelin With Modified T Cells

Cancer Discovery
Oncology
2015English

Mesothelin Targeted Cancer Immunotherapy

European Journal of Cancer
Cancer ResearchOncology
2008English

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

Frontiers in Immunology
AllergyImmunology
2018English

Modified T Cells Home to Brain Tumors

Cancer Discovery
Oncology
2018English

Neutrophils Driving Unconventional T Cells Mediate Resistance Against Murine Sarcomas and Selected Human Tumors

Cell
BiochemistryGeneticsMolecular Biology
2019English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Adoptive T-Cell Therapy for Solid Tumors

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2017English

The Hen Model of Human Ovarian Cancer Develops Anti-Mesothelin Autoantibodies in Response to Mesothelin Expressing Tumors

Journal of Ovarian Research
GynecologyOncologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy